Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Management of Stage 1 Hypertension in Adolescents

Diagnosis and Confirmation

  • The American Heart Association recommends confirming hypertension with blood pressure measurements on three separate days 3, 2
  • For adolescents ≥13 years, stage 1 hypertension is defined as systolic BP 130-139 mmHg or diastolic BP 80-89 mmHg, according to the American College of Cardiology 4, 2
  • Ambulatory blood pressure monitoring can be used to confirm the diagnosis and rule out white coat hypertension, as suggested by the American Heart Association 2

Lifestyle Modifications

  • The American Heart Association recommends implementing a DASH dietary pattern rich in fruits, vegetables, whole grains, and low-fat dairy products 5
  • Restricting sodium intake to <1500 mg/day can help reduce blood pressure, according to the American College of Cardiology 5
  • Increasing potassium intake to 3500-5000 mg/day through diet can also help lower blood pressure, as recommended by the American Heart Association 5
  • Prescribing aerobic exercise for 90-150 minutes per week can help reduce blood pressure, according to the American College of Sports Medicine 5
  • Weight loss has a dose-response relationship of approximately 1 mmHg BP reduction per kilogram lost, as reported by the Journal of the American College of Cardiology 6

Monitoring and Pharmacological Treatment

  • The American Academy of Pediatrics recommends following up every 3-6 months during the lifestyle modification period 5
  • Monitoring for target organ damage (e.g., left ventricular hypertrophy) is crucial, according to the American Heart Association 4
  • If target BP is not reached within 3-6 months of initiating lifestyle intervention, pharmacological treatment may be considered, as recommended by the American College of Cardiology 3, 1, 2
  • ACE inhibitors or angiotensin receptor blockers (ARBs) are the recommended first-line agents for pharmacological treatment, according to the American Heart Association 3, 1, 2